Patents by Inventor Kristin L. Moffitt

Kristin L. Moffitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220378895
    Abstract: The present application is generally directed to methods for identifying immunogens from organisms and pathogens, and in particular for identifying immunogens which when administered as vaccines elicit a cellular and/or humoral immune response. The present application is also directed to pneumococcal T-cell immunogens, and vaccine compositions comprising one or a combination of pneumococcal immunogens and methods for treating or preventing pneumococcal infections using the vaccines thereof. The present invention also encompasses use of the pneumococcal immunogens for diagnostic purposes to identify a subject with a pneumococcal infection.
    Type: Application
    Filed: January 7, 2022
    Publication date: December 1, 2022
    Applicant: Children's Medical Center Corporation
    Inventors: Richard Malley, Yingjie Lu, Kristin L. Moffitt
  • Patent number: 11235047
    Abstract: The present application is generally directed to methods for identifying immunogens from organisms and pathogens, and in particular for identifying immunogens which when administered as vaccines elicit a cellular and/or humoral immune response. The present application is also directed to pneumococcal T-cell immunogens, and vaccine compositions comprising one or a combination of pneumococcal immunogens and methods for treating or preventing pneumococcal infections using the vaccines thereof. The present invention also encompasses use of the pneumococcal immunogens for diagnostic purposes to identify a subject with a pneumococcal infection.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: February 1, 2022
    Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Richard Malley, Yingjie Lu, Kristin L. Moffitt
  • Publication number: 20170028050
    Abstract: The present application is generally directed to methods for identifying immunogens from organisms and pathogens, and in particular for identifying immunogens which when administered as vaccines elicit a cellular and/or humoral immune response. The present application is also directed to pneumococcal T-cell immunogens, and vaccine compositions comprising one or a combination of pneumococcal immunogens and methods for treating or preventing pneumococcal infections using the vaccines thereof. The present invention also encompasses use of the pneumococcal immunogens for diagnostic purposes to identify a subject with a pneumococcal infection.
    Type: Application
    Filed: June 28, 2016
    Publication date: February 2, 2017
    Applicant: Children's Medical Center Corporation
    Inventors: Richard Malley, Yingjie Lu, Kristin L. Moffitt
  • Publication number: 20130039947
    Abstract: The present application is generally directed to methods for identifying immunogens from organisms and pathogens, and in particular for identifying immunogens which when administered as vaccines elicit a cellular and/or humoral immune response. The present application is also directed to pneumococcal T-cell immunogens, and vaccine compositions comprising one or a combination of pneumococcal immunogens and methods for treating or preventing pneumococcal infections using the vaccines thereof. The present invention also encompasses use of the pneumococcal immunogens for diagnostic purposes to identify a subject with a pneumococcal infection.
    Type: Application
    Filed: March 11, 2011
    Publication date: February 14, 2013
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Richard Malley, Yingjie Lu, Kristin L. Moffitt
  • Publication number: 20110159040
    Abstract: An aspect of the present invention provides for methods for identifying novel immunogens that when administered as vaccines elicit a cellular or humoral immunogenic response. In a particular embodiment, a method identified pneumococcal T-cell immunogens that elicit systemic IL-17A responses, and reduce or protect against pneumococcal colonization.
    Type: Application
    Filed: December 30, 2010
    Publication date: June 30, 2011
    Applicant: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Richard Malley, Yingjie Lu, Kristin L. Moffitt